Als nächstes

Automatisches Abspielen

Emerging novel agents for the treatment of mastocytosis

1 Ansichten • 07/09/23
Aktie
Einbetten
administrator
administrator
Abonnenten
0

Tracy George, MD, ARUP Laboratories, University of Utah, Salt Lake City, UT comments on the movement from broad, cladribine-based regimens to novel, targeted tyrosine kinase inhibitors (TKIs) such as avapritinib, for the treatment of systemic mastocytosis. Dr George also comments on the future development of antibody-based therapies, emphasizing the importance of more selective agents with fewer side effects. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Zeig mehr
0 Bemerkungen sort Sortiere nach
Facebook Kommentare

Als nächstes

Automatisches Abspielen